it remains uncertain whether there is differential risk with particular coxib agents. Present data suggest that the highest risk is associated with rofecoxib; the data obtained from celecoxib ...
All 123 patients had a flare of OA at baseline, according to the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and received celecoxib 200 mg once daily for 7 days.
Find all the commercial and brand names of generic drug called Celecoxib. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...
Studies that compared a coxib with a nonselective NSAID and provided data concerning our outcomes of interest were included and categorized by the outcome variable, as well as by the specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results